Skip to content

A study on Siddha Medicine (Maruthampattai chooranam) for Dyslipidemia among Outpatients attending Ayothidoss pandithar hospital.

An Open Phase II Clinical trial to evaluate the therapeutic effectiveness of Maruthampattai chooranam in the management of Athimetham(Dyslipidemia) among Outpatients attending Ayothidoss Pandithar Hospital,National Institute of Siddha - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/084294
Enrollment
30
Registered
2025-04-07
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E785- Hyperlipidemia, unspecified

Interventions

Intervention1: Maruthampattai chooranam: Maruthampattai chooranam-2 grams Bd with Hotwater, Oral route of administration for the period of 90 days Control Intervention1: NOT APPLICABLE: NOT APPLICABLE

Sponsors

National Institute of Siddha
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Participants attending Obesity Special OPD will be screened for Dyslipidemia. 2.Participants with newly identified Dyslipidemia will be included. 3.Participants having any one or all of the following altered lipid levels will be selected. (ATP III Guidelines, NCEP-National Cholesterol Education Program) Total cholesterol more than 200mg/dl LDL cholesterol more than 130mg/dl HDL cholesterol less than 40 mg/dl Triglyceride more than 150 mg/dl

Exclusion criteria

Exclusion criteria: 1.Participants with chronic kidney diseases. 2.Participants with Active vascular disease (e.g. Unstable angina, stroke). 3.K/C/O coronary heart disease 4.K/C/O Liver diseases such as Hepatitis, Cirrhosis. 5.K/C/O Thyroid dysfuntion. 6.Chronic Smokers/Alcoholics

Design outcomes

Primary

MeasureTime frame
Outcome of the Study will be assessed by comparing the changes in the Lipid Profile before and after Treatment.Timepoint: at Baseline and 12 weeks

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr H Vetha Merlin Kumari

National Institute of Siddha

drlakshmiramaswamy@gmail.com9025575185

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026